This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Ken Solt: Innovator in Anesthesia Reversal
Introduction
Ken Solt is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of anesthesia through his innovative patents. With a total of 2 patents, his work focuses on methods and compositions that enhance patient care during and after anesthesia.
Latest Patents
Ken Solt's latest patents include groundbreaking inventions aimed at reversing sedation and general anesthesia. One patent details the use of dextroamphetamine and lisdexamfetamine to reverse dexmedetomidine sedation. This invention encompasses methods and compositions for intravenous administration, which can effectively facilitate the reversal of sedation. Another patent addresses the reversal of general anesthesia through the administration of agents such as methylphenidate, amphetamine, modafinil, amantadine, and caffeine. This invention aims to improve the awakening process from anesthesia while minimizing the occurrence of delirium.
Career Highlights
Ken Solt is associated with The General Hospital Corporation, where he applies his expertise in anesthesia and pharmacology. His innovative approaches have the potential to transform patient recovery experiences and enhance safety during surgical procedures.
Collaborations
Ken has collaborated with esteemed colleagues, including Emery Neal Brown and Oluwaseun Johnson-Akeju. These partnerships have contributed to the advancement of research in anesthesia and sedation reversal.
Conclusion
Ken Solt's contributions to the field of anesthesia through his patents demonstrate his commitment to improving patient outcomes. His innovative methods and compositions are paving the way for safer and more effective anesthesia practices.